We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Vanguard FTSE Pacific ETF
VPL
$8.56B
| $6.18M | 0.02% |
88,300
-1,395
| -2% | -$101K |
|
|
MRO
577
DELISTED
Marathon Oil Corporation
MRO
| $6.17M | 0.02% |
295,640
-233,449
| -44% | -$4.6M |
|
578
Suncor Energy
SU
$84.1B
| $6.17M | 0.02% |
151,602
-22,856
| -13% | -$891K |
|
579
Southern Company
SO
$98.9B
| $6.16M | 0.02% |
132,914
-3,361
| -2% | -$150K |
|
580
Amkor Technology
AMKR
$11.5B
| $6.13M | 0.02% |
713,000
| – | – |
|
581
ICF International
ICFI
$1.59B
| $6.13M | 0.02% |
86,200
+45,542
| +112% | +$3.09M |
|
582
TriNet
TNET
$3.18B
| $6.12M | 0.02% |
109,400
+11,700
| +12% | +$616K |
|
583
Southwest Gas
SWX
$6.29B
| $6.08M | 0.02% |
79,700
-7,200
| -8% | -$526K |
|
584
Genuine Parts
GPC
$18.1B
| $6.08M | 0.02% |
66,215
-3,285
| -5% | -$300K |
|
585
Builders FirstSource
BLDR
$6.48B
| $6.02M | 0.02% |
329,300
-127,700
| -28% | -$2.44M |
|
|
MTOR
586
DELISTED
MERITOR, Inc.
MTOR
| $6M | 0.02% |
291,900
| – | – |
|
587
Verisk Analytics
VRSK
$23.4B
| $5.99M | 0.02% |
55,644
-110
| -0.2% | -$11.7K |
|
588
MetLife
MET
$62.4B
| $5.98M | 0.02% |
137,188
-707
| -0.5% | -$33K |
|
|
AKAO
589
DELISTED
Achaogen Inc
AKAO
| $5.95M | 0.02% |
687,436
+72,297
| +12% | +$881K |
|
590
Bank OZK
OZK
$5.36B
| $5.94M | 0.02% |
131,880
-28,930
| -18% | -$1.38M |
|
|
FBC
591
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $5.92M | 0.02% |
172,900
+19,700
| +13% | +$686K |
|
592
Qualys
QLYS
$6.41B
| $5.91M | 0.02% |
70,081
+28,614
| +69% | +$2.3M |
|
593
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.3B
| $5.9M | 0.02% |
105,040
-62,400
| -37% | -$3.49M |
|
594
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $5.87M | 0.02% |
93,580
+600
| +0.6% | +$39.3K |
|
|
NXGN
595
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $5.84M | 0.02% |
299,300
-52,500
| -15% | -$830K |
|
596
United Therapeutics
UTHR
$21.5B
| $5.79M | 0.02% |
51,188
-133
| -0.3% | -$14.6K |
|
597
Broadridge
BR
$19.4B
| $5.78M | 0.02% |
50,204
+14,052
| +39% | +$1.59M |
|
598
Archer Daniels Midland
ADM
$41.7B
| $5.74M | 0.02% |
125,179
-204,921
| -62% | -$9.2M |
|
599
Coherus Oncology
CHRS
$205M
| $5.72M | 0.02% |
408,883
+5,203
| +1% | +$74.5K |
|
600
Logitech
LOGI
$14.5B
| $5.71M | 0.02% |
130,075
-7,675
| -6% | -$310K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.